{"Symbol": "AMGN", "AssetType": "Common Stock", "Name": "Amgen Inc", "Description": "Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.", "CIK": "318154", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - GENERAL", "Address": "ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, UNITED STATES, 91320-1799", "OfficialSite": "https://www.amgen.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "198993412000", "EBITDA": "17063999000", "PERatio": "25.98", "PEGRatio": "1.136", "BookValue": "16.06", "DividendPerShare": "9.52", "DividendYield": "0.0262", "EPS": "14.21", "RevenuePerShareTTM": "68.31", "ProfitMargin": "0.21", "OperatingMarginTTM": "0.282", "ReturnOnAssetsTTM": "0.0815", "ReturnOnEquityTTM": "1.061", "RevenueTTM": "36751000000", "GrossProfitTTM": "26013999000", "DilutedEPSTTM": "14.21", "QuarterlyEarningsGrowthYOY": "1.116", "QuarterlyRevenueGrowthYOY": "0.086", "AnalystTargetPrice": "345.56", "AnalystRatingStrongBuy": "4", "AnalystRatingBuy": "10", "AnalystRatingHold": "15", "AnalystRatingSell": "2", "AnalystRatingStrongSell": "1", "TrailingPE": "25.98", "ForwardPE": "16.81", "PriceToSalesRatioTTM": "5.41", "PriceToBookRatio": "22.98", "EVToRevenue": "6.65", "EVToEBITDA": "20.84", "Beta": "0.472", "52WeekHigh": "382.47", "52WeekLow": "253.48", "50DayMovingAverage": "338.01", "200DayMovingAverage": "305.12", "SharesOutstanding": "539000000", "SharesFloat": "537615000", "PercentInsiders": "0.216", "PercentInstitutions": "84.716", "DividendDate": "2026-03-06", "ExDividendDate": "2026-02-13"}